menu
    • menu

    Company profile for Custopharm

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Custopharm has assembled a highly experienced team of industry executives to lead and grow our company. Our executive team has deep expertise in sterile injectable pharmaceutical products and a strong track record of success. Custopharm is actively pursuing new product and partnership opportunities. We are looking to acquire sterile injectable products, strategically partner with development and manufacturing companies, and pr...
    Custopharm has assembled a highly experienced team of industry executives to lead and grow our company. Our executive team has deep expertise in sterile injectable pharmaceutical products and a strong track record of success. Custopharm is actively pursuing new product and partnership opportunities. We are looking to acquire sterile injectable products, strategically partner with development and manufacturing companies, and provide enhanced support for our regulatory services partners.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CustopharmUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2325 Camino Vida Roble, Carlsbad California 92011
    Telephone
    Telephone
    760 683 0901
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://custopharm.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/custopharm/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FTC requires Hikma to let go of steroid drug, post $375M Custopharm acquisition
    FTC requires Hikma to let go of steroid drug, post $375M Custopharm acquisition

    20 Apr 2022

    // Z. Brennan ENDPTS

    https://endpts.com/ftc-requires-hikma-to-let-go-of-steroid-drug-as-part-of-375m-acquisition-of-custopharm/

    Z. Brennan ENDPTS
    20 Apr 2022
    Share Share
    Hikma's $425M injectables buy will face FTC scrutiny
    Hikma's $425M injectables buy will face FTC scrutiny

    28 Sep 2021

    // Angus Liu FIERCEPHARMA

    https://www.fiercepharma.com/pharma/u-s-ftc-review-looms-as-hikma-bolsters-injectables-franchise-425m-deal-for-custopharm

    Angus Liu FIERCEPHARMA
    28 Sep 2021
    Share Share
    Enforcement Report - Week of September 1, 2021
    Enforcement Report - Week of September 1, 2021

    01 Sep 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-1-2021-1630499458.pdf

    FDA
    01 Sep 2021
    Share Share
    Custopharm`s Generic Calcitonin salmon Receives Approval in US
    Custopharm`s Generic Calcitonin salmon Receives Approval in US

    18 May 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212416

    FDA
    18 May 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search